Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Annals of Hematology
|
June 1, 1992
Prevention of viral infections after bone marrow transplantation
U Schuler, G Ehninger
Bone Marrow Transplantation
|
January 1, 1994
New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients
U Schuler, G Ehninger
Drug Safety
|
June 1, 1995
Thalidomide: rationale for renewed use in immunological disorders
U Schuler, G Ehninger
Schmerz (Berlin, Germany)
|
March 16, 2017
[Chemotherapy-induced peripheral neuropathy and neuropathic pain]
U Schuler, S Heller
Mycoses
|
January 1, 1995
[Prophylaxis and therapy of fungal infections in oncology]
U Schuler, M Mölle, G Ehninger
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites
U Schuler, G Ehninger, T Wagner
Onkologie
|
August 1, 1987
[Pharmacokinetic aspects in the use of new cytostatic drugs]
G Ehninger, U Schuler, H D Waller
International Journal of Food Microbiology
|
August 1, 1990
Temperature limits of growth, TNase and enterotoxin production of Staphylococcus aureus strains isolated from foods
M Schmitt, U Schuler-Schmid, W Schmidt-Lorenz
Bone Marrow Transplantation
|
January 1, 1993
Thalidomide--the need for a new clinical evaluation of an old drug
G Ehninger, K Eger, A Stuhler, et al.
European Journal of Gastroenterology & Hepatology
|
November 27, 1998
Abdominal lymphomas, convulsive seizure and coma: a case of successfully treated, advanced Whipple's disease with cerebral involvement
J Mohm, R Naumann, U Schuler, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Annals of Hematology
|
June 1, 1992
Prevention of viral infections after bone marrow transplantation
U Schuler, G Ehninger
Bone Marrow Transplantation
|
January 1, 1994
New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients
U Schuler, G Ehninger
Drug Safety
|
June 1, 1995
Thalidomide: rationale for renewed use in immunological disorders
U Schuler, G Ehninger
Schmerz (Berlin, Germany)
|
March 16, 2017
[Chemotherapy-induced peripheral neuropathy and neuropathic pain]
U Schuler, S Heller
Mycoses
|
January 1, 1995
[Prophylaxis and therapy of fungal infections in oncology]
U Schuler, M Mölle, G Ehninger
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites
U Schuler, G Ehninger, T Wagner
Onkologie
|
August 1, 1987
[Pharmacokinetic aspects in the use of new cytostatic drugs]
G Ehninger, U Schuler, H D Waller
International Journal of Food Microbiology
|
August 1, 1990
Temperature limits of growth, TNase and enterotoxin production of Staphylococcus aureus strains isolated from foods
M Schmitt, U Schuler-Schmid, W Schmidt-Lorenz
Bone Marrow Transplantation
|
January 1, 1993
Thalidomide--the need for a new clinical evaluation of an old drug
G Ehninger, K Eger, A Stuhler, et al.
European Journal of Gastroenterology & Hepatology
|
November 27, 1998
Abdominal lymphomas, convulsive seizure and coma: a case of successfully treated, advanced Whipple's disease with cerebral involvement
J Mohm, R Naumann, U Schuler, et al.
Page
of 5